Natalizumab. Treatment of IBD, Treatment of multiple sclerosis

被引：5
|
作者：
Sorbera, LA [1 ]
Martin, L [1 ]
Rabasseda, X [1 ]
机构：
[1] Prous Sci, Barcelona 08080, Spain
来源：
DRUGS OF THE FUTURE | 2000年 / 25卷 / 09期
关键词：
immunoglobulin G 4 (human-mouse monoclonal AN100226 gamma-chain anti-human integrin 4); disulfide with human-mouse; monoclonal AN100226 light chain; dimer;
D O I：
10.1358/dof.2000.025.09.593332
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：917 / 921
页数：5
相关论文
共 50 条
  • [41] An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosis
    Horga, Alejandro
    Castillo, Joaquin
    Rio, Jordi
    Tintore, Mar
    Auger, Cristina
    Sastre-Garriga, Jaume
    Carmen Edo, M.
    Perez-Miralles, Francisco
    Tur, Carmen
    Nos, Carlos
    Huerga, Elena
    Comabella, Manuel
    Rovira, Alex
    Montalban, Xavier
    REVISTA DE NEUROLOGIA, 2011, 52 (06) : 321 - 330
  • [42] Eosinophilic Fasciitis Occurring under Treatment with Natalizumab for Multiple Sclerosis
    Bujold, Janie
    Boivin, Catherine
    Amin, Mohamed
    Bouchard, Jean-Pierre
    Soucy, Jacques
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2014, 18 (01) : 69 - 71
  • [43] Does natalizumab have a role in the treatment of relapsing multiple sclerosis?
    Stangel, Martin
    NATURE CLINICAL PRACTICE NEUROLOGY, 2006, 2 (09): : 476 - 477
  • [44] Cerebral abscess in a multiple sclerosis patient during treatment with natalizumab
    B. Durmus
    J. Van Goethem
    A. Vercruyssen
    G. De la Meilleure
    C. Jadoul
    B. Willekens
    Acta Neurologica Belgica, 2020, 120 : 215 - 217
  • [45] Exacerbation of multiple sclerosis after withdrawal and restart of treatment with natalizumab
    Beume, L.
    Dersch, R.
    Fuhrer, H.
    Guggenmoos, S.
    Stich, O.
    Rauer, S.
    Niesen, W.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 464 - 464
  • [46] Natalizumab treatment in multiple sclerosis - an experience from Malaga, Spain
    Papais Alvarenga, M.
    Fernandez, V.
    Guerrero, M.
    Luque, G.
    Oliver, B.
    Leyva, L.
    Fernandez, O.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S233 - S233
  • [47] Reduction of relapses in multiple sclerosis after natalizumab (antegren) treatment
    Sheremata, WA
    Minagar, A
    Hume, A
    Koller, M
    Vollmer, T
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 507 - 507
  • [48] Clinical efficacy issues in the treatment of multiple sclerosis: update of natalizumab
    Patti, Francesco
    Pappalardo, Angelo
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2009, 1 : 45 - 51
  • [49] Catastrophic multiple sclerosis rebound after natalizumab treatment discontinuation
    Tur, C.
    Tintore, M.
    Vidal-Jordana, A.
    Rio, J.
    Wing, A. C.
    Canneti, B.
    Torres, M.
    Arevalo, M. J.
    Castillo, J.
    Galan, I.
    Horno, R.
    Vicente, M. J.
    Martin, M. I.
    Comabella, M.
    Rovira, A.
    Sastre-Garriga, J.
    Montalban, X.
    JOURNAL OF NEUROLOGY, 2013, 260 : S14 - S14
  • [50] From injection therapies to natalizumab: views on the treatment of multiple sclerosis
    Bomprezzi, Roberto
    Okuda, Darin T.
    Alderazi, Yazan J.
    Stueve, Olaf
    Frohman, Elliot M.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2012, 5 (02) : 97 - 104
12345